193 related articles for article (PubMed ID: 30814996)
1. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
Zhang S; Lin X
Front Immunol; 2019; 10():176. PubMed ID: 30814996
[TBL] [Abstract][Full Text] [Related]
2. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
McAuley JR; Freeman TJ; Ekambaram P; Lucas PC; McAllister-Lucas LM
Front Immunol; 2018; 9():1887. PubMed ID: 30158935
[TBL] [Abstract][Full Text] [Related]
3. CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection.
Jiang C; Zhou Z; Quan Y; Zhang S; Wang T; Zhao X; Morrison C; Heise MT; He W; Miller MS; Lin X
Cell Rep; 2016 Mar; 14(10):2389-401. PubMed ID: 26947079
[TBL] [Abstract][Full Text] [Related]
4. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
Grabiner BC; Blonska M; Lin PC; You Y; Wang D; Sun J; Darnay BG; Dong C; Lin X
Genes Dev; 2007 Apr; 21(8):984-96. PubMed ID: 17438001
[TBL] [Abstract][Full Text] [Related]
5. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
6. CARMA3: A potential therapeutic target in non-cancer diseases.
Gui Z; Zhang Y; Zhang A; Xia W; Jia Z
Front Immunol; 2022; 13():1057980. PubMed ID: 36618379
[TBL] [Abstract][Full Text] [Related]
7. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
[TBL] [Abstract][Full Text] [Related]
9. Regulation of NF-κB by the CARD proteins.
Jiang C; Lin X
Immunol Rev; 2012 Mar; 246(1):141-53. PubMed ID: 22435552
[TBL] [Abstract][Full Text] [Related]
10. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B.
Wang L; Guo Y; Huang WJ; Ke X; Poyet JL; Manji GA; Merriam S; Glucksmann MA; DiStefano PS; Alnemri ES; Bertin J
J Biol Chem; 2001 Jun; 276(24):21405-9. PubMed ID: 11259443
[TBL] [Abstract][Full Text] [Related]
11. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases.
Sun J
World J Biol Chem; 2010 Dec; 1(12):353-61. PubMed ID: 21537470
[TBL] [Abstract][Full Text] [Related]
12. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
13. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
[TBL] [Abstract][Full Text] [Related]
14. NF-κB signaling pathways regulated by CARMA family of scaffold proteins.
Blonska M; Lin X
Cell Res; 2011 Jan; 21(1):55-70. PubMed ID: 21187856
[TBL] [Abstract][Full Text] [Related]
15. The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation.
D'Andrea EL; Ferravante A; Scudiero I; Zotti T; Reale C; Pizzulo M; De La Motte LR; De Maio C; Mazzone P; Telesio G; Vito P; Stilo R
PLoS One; 2014; 9(12):e116062. PubMed ID: 25541973
[TBL] [Abstract][Full Text] [Related]
16. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract][Full Text] [Related]
17. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
McAllister-Lucas LM; Jin X; Gu S; Siu K; McDonnell S; Ruland J; Delekta PC; Van Beek M; Lucas PC
J Biol Chem; 2010 Aug; 285(34):25880-4. PubMed ID: 20605784
[TBL] [Abstract][Full Text] [Related]
18. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
[TBL] [Abstract][Full Text] [Related]
19. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.
Sun J; Lin X
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17085-90. PubMed ID: 18952848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
